Intestinal glycocalyx (GCX)

The intestinal glycocalyx is a dense, carbohydrate-rich layer covering the apical surface of the intestinal epithelium, specifically the microvilli of enterocytes [Biology Online, Wikipedia]. It is composed of a complex network of membrane-bound mucins, proteoglycans such as syndecans, and glycosaminoglycans including heparan sulfate and hyaluronan that form a critical physical and chemical barrier [NIH, MDPI]. This structure serves dual roles: it anchors essential digestive enzymes to facilitate nutrient breakdown and absorption while simultaneously acting as a primary defense mechanism to exclude pathogens and toxins from the systemic circulation [Biology Online, Study.com]. In diseases such as inflammatory bowel disease (IBD), sepsis, and severe acute pancreatitis, the glycocalyx undergoes significant degradation or shedding, which compromises the intestinal barrier and leads to increased permeability and systemic inflammation [NIH, ResearchGate]. Therapeutic strategies are currently focused on protecting this layer from enzymatic degradation or replenishing its components using exogenous glycosaminoglycans to restore gut homeostasis and prevent disease progression [NIH, MDPI].

Other names

Enteric glycocalyxGut glycocalyxMucosal glycocalyxEpithelial glycocalyx of the intestinePericellular matrix of the intestine

Restoration of the carbohydrate-rich surface layer by providing exogenous building blocks (e.g., hyaluronan, heparan sulfate) or by inhibiting sheddase enzymes like heparanase and matrix metalloproteinases that degrade the structure during inflammation [NIH, MDPI].